All Resources

The Alberta Aids to Daily Living (AADL) bulletin [151 to current]

Description

Alberta Aids to Daily Living assists Albertans with a long-term disability, chronic illness or terminal illness, in maintaining independence in their community. AADL provides funding for basic... More ≫

Description

Alberta Aids to Daily Living assists Albertans with a long-term disability, chronic illness or terminal illness, in maintaining independence in their community. AADL provides funding for basic medical equipment and supplies to meet clinically assessed needs. The AADL bulletin provides notices, updates and reminders to AADL providers, vendors, suppliers and other interested parties.

Tags

Alberta sexually transmitted infections and HIV

Description

This annual report provides a high-level overview of four notifiable sexually transmitted and blood-borne infections: chlamydia, gonorrhea, HIV, and infectious syphilis. Focus is placed on... More ≫

Description

This annual report provides a high-level overview of four notifiable sexually transmitted and blood-borne infections: chlamydia, gonorrhea, HIV, and infectious syphilis. Focus is placed on examining counts and rates of for the current year within the context of previous years and Alberta Health Services Zones.

Tags

Alberta Aids to Daily Living program manual Section GN : general policy and procedures

Description

The Alberta Aids to Daily Living (AADL) program manual includes information on eligibility, cost-share exemption, quantity and frequency review requests and vendor, authorizer and specialty... More ≫

Description

The Alberta Aids to Daily Living (AADL) program manual includes information on eligibility, cost-share exemption, quantity and frequency review requests and vendor, authorizer and specialty supplier roles and responsibilities. The program manual also includes policies and procedures for each benefit area and approved product lists. The manual is broken into sections for easier reference.

Tags

Alberta Biomonitoring Program: Chemicals in Serum of Pregnant Women and Children in Alberta

Description

Biomonitoring provides a measure of internal doses of environmental chemicals or agents and allows for a more accurate measure of human health risk from these exposures. In these Alberta... More ≫

Description

Biomonitoring provides a measure of internal doses of environmental chemicals or agents and allows for a more accurate measure of human health risk from these exposures. In these Alberta Biomonitoring Program datasets, information was collected as part of 3 province-wide studies investigating the serum levels of environmental chemicals (both natural and synthetic) in pregnant women in northern, central and southern Alberta (Phase 1), in children in southern Alberta (Phase 2), and maternal and umbilical cord blood samples from 7 Alberta cities (Phase 3). The goals of the program are to create a benchmark against which to track future exposures, provide a starting point for assessing health risks, indicate possible exposure sources and prioritize research efforts. Chemicals targeted for monitoring were selected using expert guidance and review of similar studies. For Phases 1 and 2, results for each chemical are presented in a single column, as either whole serum or lipid-adjusted...

Tags

Alberta Aids to Daily Living program manual Section H : amplification benefits

Description

The Alberta Aids to Daily Living (AADL) program manual includes information on eligibility, cost-share exemption, quantity and frequency review requests and vendor, authorizer and specialty... More ≫

Description

The Alberta Aids to Daily Living (AADL) program manual includes information on eligibility, cost-share exemption, quantity and frequency review requests and vendor, authorizer and specialty supplier roles and responsibilities. The program manual also includes policies and procedures for each benefit area and approved product lists. The manual is broken into sections for easier reference.

Tags

Cyanobacterial blooms in Alberta recreational waters

Description

Cyanobacteria (also referred to as blue-green algae) are common photosynthetic bacteria that live in surface waters. Under favorable conditions, such as warm water and high nutrient content, these... More ≫

Description

Cyanobacteria (also referred to as blue-green algae) are common photosynthetic bacteria that live in surface waters. Under favorable conditions, such as warm water and high nutrient content, these bacteria can form nuisance “blooms”. The presence of blooms in recreational water causes unpleasant aesthetics and exposure to some toxin-producing blooms may pose potential health risks. Contact with blooms can cause skin rashes and irritation, itchy eyes, and ear infections. Inhaling water may cause allergic-like reactions, runny noses or sore throats. Ingestion of toxins can cause a range of symptoms (e.g., hepatotoxic or neurotoxic effects, and even death). There has been increased public awareness as a result of research over the past 20 years, recent monitoring efforts, and increased public education on the topic. In 2009, Alberta Health and Alberta Health Services began seasonal monitoring for cyanobacterial blooms at high use recreational beaches. In 2019, beach operators took over...

Tags

Health indicator : singleton large for gestational age percent : by geography

Description

This dataset presents information on singleton LGA, that is the percentage of singleton live births over a year that are large for gestational-age at birth.

Tags

Health indicator : singleton large for gestational age percent : by mother's age

Description

This dataset presents information on singleton LGA, that is the percentage of singleton live births over a year that are large for gestational-age at birth.

Tags

Health indicator : high birth weight percent : by mother's age

Description

This dataset presents information on high birth weight percentage, that is the percentage of live births in a given year that are 4,000 grams or more at birth.

Tags

Opioid agonist therapy Gap Coverage Program : information for health care providers

Description

Opioid agonist therapy (OAT), which entails the provision of medications like buprenorphine/naloxone or methadone, is an evidence-based treatment option for opioid use disorder. This fact sheet... More ≫

Description

Opioid agonist therapy (OAT), which entails the provision of medications like buprenorphine/naloxone or methadone, is an evidence-based treatment option for opioid use disorder. This fact sheet provides information for health care providers about the OAT Gap Coverage Program, which is designed to provide immediate, no-cost access to OAT drugs for patients who do not have supplementary health benefit coverage.

Tags